INMB INMUNE BIO INC Capital Structure Changes 8-K Filing 2024 - Rights Agreement Extension Inmune Bio Inc. extended its Rights Agreement to December 30, 2025, and granted stock options to its non-employee directors and executives, totaling 1,000,500 shares at an exercise price of $5.05, vesting in 2026.Get access to all SEC 8-K filings of the INMUNE BIO INC